MENU
NEXI
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

NexImmune (NEXI) Ownership - Who owns NexImmune?

NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
348.67K
P/E Ratio
N/A
Total Cash
2.42M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash/Share
1.74
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Who owns NexImmune? NEXI symbol Ownership - Tickeron.com